Related Experiment Video
Updated: Jun 10, 2026
16:27
Strategies for Study of Neuroprotection from Cold-preconditioning
Published on: September 2, 2010
Prospects for minocycline neuroprotection
Jennifer M Plane1, Yan Shen, David E Pleasure
1Department of Cell Biology and Human Anatomy, University of California, Davis, Sacramento, 95817, USA.
Archives of Neurology
|August 11, 2010
Summary
Minocycline, an antibiotic, shows neuroprotective effects in various neurological disease models. This review critically examines its biological basis and potential for treating nervous system disorders.
Area of Science:
- Neuroscience
- Pharmacology
- Drug Discovery
Background:
- Minocycline is an established antibiotic and anti-inflammatory agent.
- It exhibits neuroprotective properties across diverse experimental neurological disease models.
- Over 300 publications, including human studies, support its neuroprotective actions.
Purpose of the Study:
- To critically review the biological mechanisms underlying minocycline's neuroprotection.
- To evaluate the translational potential of minocycline for nervous system disorders.
Main Methods:
- Literature review of experimental and clinical studies on minocycline's neuroprotective effects.
- Analysis of biological pathways and targets involved in minocycline's action on the nervous system.
Main Results:
- Minocycline modulates multiple neuroinflammatory and neurotoxic pathways.
- Evidence suggests efficacy in models of stroke, Alzheimer's disease, Parkinson's disease, and multiple sclerosis.
- Clinical data, though emerging, indicates potential therapeutic benefits.
Conclusions:
- Minocycline possesses a strong biological rationale for neuroprotection.
- Further clinical investigation is warranted to fully establish its therapeutic role in neurological diseases.
- Its anti-inflammatory and anti-apoptotic properties are key to its neuroprotective potential.
